Skip to content

Travere Therapeutics, Inc. TVTX Revenue recognized that was included in deferred income at the beginning of the period

Revenue recognized that was included in deferred income at the beginning of the period at other companies

Paycom Software logo
Paycom SoftwarePAYC
$9M-5.3%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$2.2M+18,233%
Churchill Downs logo
Churchill DownsCHDN
$6M0.0%
Constellium logo
ConstelliumCSTM
$12M+9.1%
Allison Transmission Holdings logo
Allison Transmission HoldingsALSN
$17M+54.5%
Baxter International logo
Baxter InternationalBAX
$46M+35.3%

Segments

By product

See full
License and collaboration revenue$2.87M-50.9%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.13B+72.3%
Enterprise value$5.07B+65.5%
P/S9.6×-1.3×

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×